Table 4.
Outcome | Overall effect |
<1 SD below mean |
1 SD below mean to mean |
Mean to 1 SD above mean |
>1 SD above mean |
Ptrend* | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | β (95% CI) | n | β (95% CI) | n | β (95% CI) | n | β (95% CI) | n | β (95% CI) | ||
All studies | |||||||||||
Fatigue† | 3846 | −0.17 (−0.22 to −0.12)‡ | 649 | −0.03 (−0.13 to 0.08) | 1430 | −0.17 (−0.25 to −0.09)‡ | 1124 | −0.20 (−0.30 to −0.11)‡ | 643 | −0.22 (−0.37 to −0.07)‡ | <.001 |
Physical function | 3984 | 0.18 (0.13 to 0.23)‡ | 649 | 0.27 (0.11 to 0.42)‡ | 890 | 0.22 (0.11 to 0.34)‡ | 1727 | 0.19 (0.12 to 0.25)‡ | 718 | 0.03 (−0.07 to 0.12) | <.001 |
During cancer treatment | |||||||||||
Aerobic fitness | 1374 | 0.25 (0.18 to 0.33)‡ | 211 | 0.07 (−0.12 to 0.26) | 510 | 0.20 (0.09 to 0.31)‡ | 453 | 0.32 (0.22 to 0.43)‡ | 200 | 0.38 (0.15 to 0.60)‡ | <.001 |
Upper body muscle strength | 1106 | 0.25 (0.16 to 0.35)‡ | – | – | – | – | – | – | – | – | – |
Lower body muscle strength | 1019 | 0.29 (0.20 to 0.37)‡ | – | – | – | – | – | – | – | – | – |
Quality of life | 1914 | 0.15 (0.07 to 0.22)‡ | – | – | – | – | – | – | – | – | – |
Post cancer treatment | |||||||||||
Aerobic fitness | 843 | 0.33 (0.24 to 0.41)‡ | – | – | – | – | – | – | – | – | – |
Upper body muscle strength | 904 | 0.10 (0.04 to 0.15)‡ | 168 | 0.21 (0.12 to 0.30)‡ | 458 | 0.19 (0.13 to 0.25)‡ | 180 | −0.04 (−0.16 to 0.08) | 98 | −0.06 (−0.17 to 0.06) | <.001 |
Lower body muscle strength | 646 | 0.26 (0.18 to 0.34)‡ | 89 | 0.38 (0.25 to 0.51)‡ | 363 | 0.30 (0.21 to 0.39)‡ | 129 | 0.20 (−0.01 to 0.40)§ | 65 | 0.03 (−0.33 to 0.40) | <.001 |
Quality of life | 1960 | 0.15 (0.09 to 0.21)‡ | 311 | 0.36 (0.17 to 0.55)‡ | 538 | 0.19 (0.06 to 0.32)‡ | 741 | 0.12 (0.03 to 0.21)‡ | 370 | −0.02 (−0.13 to 0.08) | .01 |
P value of the two-sided trend test. CI = confidence intervals; df = degrees of freedom; SD = standard deviation.
Higher scores on the fatigue scale indicate more fatigue.
P ≤ .05, P value of the two-sided linear mixed model analyses Analyses are adjusted for age, sex, and cancer type.
.05 < P ≤ .10. P value of the two-sided linear mixed model analyses. Analyses are adjusted for age, sex, and cancer type.